Trial Profile
Phase I trial of HX 100 in healthy volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 May 2017
Price :
$35
*
At a glance
- Drugs HX 100 (Primary)
- Indications Allergic asthma; Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions
- Sponsors Hydra Biosciences
- 16 Apr 2015 New trial record
- 14 Apr 2015 Health Canada has approved Hydra Biosciences' Clinical Trial Application to begin this trial, according to a media release.